This webcast features: Dr. Kiran Chodavarapu, Bioprocessing Business Development Manager at W.R. Grace.
Implementation of single-use technologies and higher antibody titers upstream have put increasing pressure on downstream processes to improve efficiencies and keep pace with upstream advancements.
There continues to be a lag in the development and adoption of single-use technologies in downstream – particularly in the area of chromatography.
To help achieve the vision of a fully disposable and flexible manufacturing platform that addresses the current bottleneck in downstream processing, a new high-capacity, incompressible Protein A resin has been developed that comes pre-packed in disposable columns. The high capacity silica and bonding chemistry maximize dynamic binding capacity while controlling non-specific protein binding.